Actualités - BIOQuébec

17 October 2025
Overview of Patent Trends in the Field of mRNA Vaccines
Messenger RNA (mRNA) vaccines represent a revolutionary advancement in the field of biotechnology. Unlike traditional vaccines...
Read More
14 October 2025
Glycovax Pharma, the National Research Council of Canada and the Université de Montréal, join forces to develop an innovative vaccine against the bacterium Pseudomonas aeruginosa (Pa), made possible through CQDM’s financial support
Glycovax Pharma announces strategic collaboration with the National Research Council of Canada (NRC) and the Faculty of Medicine...
Read More
14 October 2025
Feldan Therapeutics' shuttle technology drives collaborative initiative suppoted by grant funding through Médicament Québec to advance mRNA Therapeutics
Feldan Shuttle technology is at the heart of a collaborative research initiative supported by a grant from...
Read More
14 October 2025
Anasens and MAVAND Sign Distribution Agreement for DrugAsens™ Across Key European Markets and Australia
Anasens Inc., a developer of rapid and connected detection tools, today announced the signing of a distribution agreement with...
Read More
17 September 2025
Biotech companies and academic institutions: considerations for successful collaboration
Many companies in Quebec's biotechnology industry are interested in collaborating with one or more academic institutions...
Read More
9 September 2025
Get trained in industrial bioprocesses this fall with CNETE!
Are you looking to launch or develop your business in the field of bioprocesses...
Read More

AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec

AbbVie (NYSE : ABBV), en collaboration avec adMare BioInnovations, a annoncé aujourd’hui le lancement du Prix AbbVie des innovateurs en biotechnologies, visant à…

News &
publications

Discover our news, publications and the latest from our partners and members. Stay abreast of the advances and issues shaping Quebec's life sciences!

Overview of Patent Trends in the Field of mRNA Vaccines

Glycovax Pharma, the National Research Council of Canada and the Université de Montréal, join forces to develop an innovative vaccine against the bacterium Pseudomonas aeruginosa (Pa), made possible through CQDM’s financial support

Feldan Therapeutics' shuttle technology drives collaborative initiative suppoted by grant funding through Médicament Québec to advance mRNA Therapeutics

Anasens and MAVAND Sign Distribution Agreement for DrugAsens™ Across Key European Markets and Australia

Biotech companies and academic institutions: considerations for successful collaboration

Get trained in industrial bioprocesses this fall with CNETE!

AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec

News &publications

Discover our news, publications and the latest from our partners and members. Stay abreast of the advances and issues shaping Quebec's life sciences!

Overview of Patent Trends in the Field of mRNA Vaccines

Glycovax Pharma, the National Research Council of Canada and the Université de Montréal, join forces to develop an innovative vaccine against the bacterium Pseudomonas aeruginosa (Pa), made possible through CQDM’s financial support

Feldan Therapeutics' shuttle technology drives collaborative initiative suppoted by grant funding through Médicament Québec to advance mRNA Therapeutics

Anasens and MAVAND Sign Distribution Agreement for DrugAsens™ Across Key European Markets and Australia

Biotech companies and academic institutions: considerations for successful collaboration

Get trained in industrial bioprocesses this fall with CNETE!

AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec

News &
publications